1. Home
  2. WVE vs BRAI Comparison

WVE vs BRAI Comparison

Compare WVE & BRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Braiin Limited Common Stock

BRAI

Braiin Limited Common Stock

N/A

Current Price

$5.72

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
BRAI
Founded
2012
N/A
Country
Singapore
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
BRAI
Price
$5.55
$5.72
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$29.81
N/A
AVG Volume (30 Days)
2.3M
536.7K
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$85.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$5.15
52 Week High
$21.73
$32.32

Technical Indicators

Market Signals
Indicator
WVE
BRAI
Relative Strength Index (RSI) 38.55 43.22
Support Level $5.49 $5.15
Resistance Level $6.48 $11.54
Average True Range (ATR) 0.24 0.68
MACD -0.01 0.12
Stochastic Oscillator 25.16 11.97

Price Performance

Historical Comparison
WVE
BRAI

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BRAI Braiin Limited Common Stock

Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.

Share on Social Networks: